Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX)
CUSIP: 01438T106
Q4 2015 13F Holders as of 31 Dec 2015
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 59,794,743
- Total 13F shares
- 4,427,755
- Share change
- +34,559
- Total reported value
- $30,018,000
- Price per share
- $6.78
- Number of holders
- 20
- Value change
- +$376,484
- Number of buys
- 3
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 01438T106?
CUSIP 01438T106 identifies ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 01438T106:
Top shareholders of ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
2.4%
|
1,437,811
|
$8,382,000 | — | 30 Sep 2015 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.6%
|
957,193
|
$5,580,000 | — | 30 Sep 2015 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.2%
|
690,538
|
$4,026,000 | — | 30 Sep 2015 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.44%
|
265,000
|
$1,545,000 | — | 30 Sep 2015 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.24%
|
142,000
|
$828,000 | — | 30 Sep 2015 | |
| Knoll Capital Management, LLC |
13F
|
Company |
0.23%
|
135,800
|
$792,000 | — | 30 Sep 2015 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
0.23%
|
134,997
|
$787,000 | — | 30 Sep 2015 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.19%
|
116,100
|
$677,000 | — | 30 Sep 2015 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.18%
|
107,270
|
$626,000 | — | 30 Sep 2015 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.13%
|
76,000
|
$443,000 | — | 30 Sep 2015 | |
| Nicholas Investment Partners, LP |
13F
|
Company |
0.11%
|
63,666
|
$371,000 | — | 30 Sep 2015 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.11%
|
63,605
|
$371,000 | — | 30 Sep 2015 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.1%
|
57,500
|
$335,000 | — | 30 Sep 2015 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
22,558
|
$131,000 | — | 30 Sep 2015 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
20,496
|
$119,000 | — | 30 Sep 2015 | |
| Spark Investment Management LLC |
13F
|
Company |
0.03%
|
18,400
|
$105,000 | — | 30 Sep 2015 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.02%
|
12,286
|
$71,000 | — | 30 Sep 2015 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0%
|
2,978
|
$17,000 | — | 30 Sep 2015 | |
| Vantage Investment Advisors, LLC |
13F
|
Company |
0%
|
2,000
|
$12,000 | — | 30 Sep 2015 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,589
|
$9,000 | — | 30 Sep 2015 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,305
|
$8,000 | — | 30 Sep 2015 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0%
|
958
|
$6,000 | — | 30 Sep 2015 |
Institutional Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q4 2015
As of 31 Dec 2015,
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,427,755 shares.
The largest 10 holders included
FMR LLC, PERCEPTIVE ADVISORS LLC, DEERFIELD MANAGEMENT CO, SPHERA FUNDS MANAGEMENT LTD., BAKER BROS. ADVISORS LP, Knoll Capital Management, LP, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, Weiss Multi-Strategy Advisers LLC, and SABBY MANAGEMENT, LLC.
This page lists
20
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2015 vs Q3 2015 Across Filers
Q3 2015 holders
22
Q4 2015 holders
20
Holder diff
-2
| Investor | Q3 2015 Shares | Q4 2015 Shares | Share Diff | Share Chg % | Q3 2015 Value $ | Q4 2015 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.